Share
Journal Information
Most Often Read
882
Document of recommendations of the SEA 2018. Lifestyle in cardiovascular preventionFrancisco Pérez-Jiménez, Vicente Pascual, José Félix Meco, Pablo Pérez Martínez, Javier Delgado Lista, Monica Domenech, Ramon Estruch, Ana León-Acuña, José López-Miranda, Andrea Sánchez-Ramos, Cristina Soler i Ferrer, Cristina Soler-Rivas, Rosa Maria Solá Alberich, Pedro Valdivielso, Emilio Ros
Clin Investig Arterioscler. 2018;30:280-310
882
Open access
598
Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Society of Arteriosclerosis (SEA), 2019Juan Francisco Ascaso, Fernando Civeira, Carlos Guijarro, José López Miranda, Luis Masana, José María Mostaza, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso
Clin Investig Arterioscler. 2019;31:128-39
598
Open access
71
Chronic kidney disease and dyslipidaemiaV. Pascual, A. Serrano, J. Pedro-Botet, J. Ascaso, V. Barrios, J. Millán, X. Pintó, A. Cases
Clin Investig Arterioscler. 2017;29:22-35
71
54
Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES studyJosé J. Gómez-Barrado, Carolina Ortiz, Marta Gómez-Turégano, Paula Gómez-Turégano, Francisco J. Garcipérez-de-Vargas, Pablo Sánchez-Calderón
Clin Investig Arterioscler. 2017;29:13-9
54
52
Is regression of atherosclerotic plaque possible?José A. Páramo, Fernando Civeira
Clin Investig Arterioscler. 2017;29:46-50
52
51
Statin associated myopathy in clinical practice. Results of DAMA studyJesús Millán, Juan Pedro-Botet, Elisenda Climent, Joaquín Millán, Joan Rius
Clin Investig Arterioscler. 2017;29:7-12
51
48
Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosisAlejandra B. Camargo, Walter Manucha
Clin Investig Arterioscler. 2017;29:36-45
48
48
A glow in the secondary prevention of cardiovascular diseaseJ. Pedro-Botet, E. Climent
Clin Investig Arterioscler. 2017;29:20-1
48
38
Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary eventEfrén Martínez-Quintana, Fayna Rodríguez-González, José María Medina-Gil, Paloma Garay-Sánchez, Antonio Tugores
Clin Investig Arterioscler. 2017;29:1-6
38
34
Vascular lesions in patient with Takayasu arteritis and massive elevated lipoprotein (a) levels. Residual involvement or premature aterosclerosis?José Carlos Alarcón García, Santiago Rodríguez Suárez, Ovidio Muñiz Grijalvo, Salvador García Morillo
Clin Investig Arterioscler. 2017;29:98-102
34
27
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of ArteriosclerosisJuan F. Ascaso, Jesús Millán, Antonio Hernández-Mijares, Mariano Blasco, Ángel Brea, Ángel Díaz, Teresa Mantilla, Juan Pedro-Botet, Xavier Pintó
Clin Investig Arterioscler. 2017;29:86-91
27
22
Differential leucocyte RNA expression in the coronary arteries compared to systemic circulation discriminates between patients with and those without coronary artery diseaseJosep Ribalta, Arash Alipour, Fátima Sánchez-Cabo, Joan-Carles Vallvé, Tjin Njo, Rebeca Álvarez, Hans Janssen, Anho Liem, Ana Dopazo, Manuel Castro-Cabezas
Clin Investig Arterioscler. 2017;29:60-6
22
20
Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicityWalter Manucha
Clin Investig Arterioscler. 2017;29:92-7
20
19
Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosisIolanda Lazaro, Ainhoa Oguiza, Carlota Recio, Laura Lopez-Sanz, Susana Bernal, Jesus Egido, Carmen Gomez-Guerrero
Clin Investig Arterioscler. 2017;29:51-9
19
15
Treatment of a high cardiovascular risk patient with McArdle's disease with PCSK9 inhibitorsVictoria Marco-Benedí, Estíbaliz Jarauta, Sofía Pérez-Calahorra, Ana M. Bea, Fernando Civeira
Clin Investig Arterioscler. 2019;31:89-92
15
12
Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseasesAntonio Ruiz-García, Ezequiel Arranz-Martínez, Juan Carlos García-Álvarez, Luis Enrique Morales-Cobos, María Eugenia García-Fernández, Nuria de la Peña-Antón, María Carmen Martín Calle, M. Cruz Díez Pérez, Alejandra Montero Costa, David Palacios Martínez, M. Paloma García Villasur, M.a Dolores García Granado, M. Soledad Lorenzo Borda, Juan A. Cique Herráinz, Nuria Marañón Henrich, Nieves Zarzuelo Martín, M. del Camino Baltuille Aller, Teresa Fátima Casaseca Calvo, Pilar Arribas Álvaro, Ana Isabel Macho del Barrio, Juan Carlos Moreno Fernández, Carlos Ribot Catalá, Mercedes Capitán Caldas, Cristina Ciria de Pablo, Carmelina Sanz Velasco, Paula Simonaggio Stancampiano, Concepción Vargas-Machuca Cabañero, M. Teresa Sarriá Sánchez, Esther Gómez Díaz, Blanca Sanz Pozo, Enrique Rodríguez de Mingo, M. Pilar Cabello Igual, M. Rosario Rico Pérez, Alfonso Migueláñez Valero, Amelia Alcaraz Bethencourt, Concepción Zafra Urango, Paula Chao Escuer, Sonia Redondo de Pedro, Nuria Escamilla Guijarro, Beatriz López Uriarte, Montserrat Rivera Teijido
Clin Investig Arterioscler. 2018;30:197-208
12
9
HSP90 inhibitors as a future therapeutic strategy in diabetes-driven atherosclerosisManuel Vázquez-Carrera
Clin Investig Arterioscler. 2017;29:67-8
9
7
Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM studyAntonio Ruiz-García, Ezequiel Arranz-Martínez, Juan Carlos García-Álvarez, María Eugenia García-Fernández, David Palacios-Martínez, Alejandra Montero-Costa, Cristina Ciria-de-Pablo, Beatriz López-Uriarte, Rosa Ana García-Pliego, Paula Chao-Escuer, Concepción Zafra-Urango, Amelia Alcaraz-Bethencourt, Sonia Redondo-de-Pedro, Nuria Escamilla-Guijarro, Teresa Pascual-Val, María Carmen Vieira-Pascual, Juncal Martínez-Irazusta, Eva Martínez-Cid-de-Rivera, Ángela Rodríguez-de-Cossío, Lidia de-Prado-Prieto, Mercedes Adrián-Sanz, María Esther Minguela-Puras, José Manuel Blanco-Canseco, Mercedes Rubio-Villar, María Luisa Berbil-Bautista, Rosa Hueso-Quesada, María Teresa Plata-Barajas, Mercedes Redondo-Sánchez, María Rosario Durán-Tejada, María Rosa García-Redondo, Miriam Sánchez-Herráiz, Ana María Rey-López, María Prado García-García-Alcañiz, Clara Abad-Schilling, Yolanda Hidalgo-Calleja, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2020;32:15-25
7
5
Update of therapeutic planning tables oriented towards obtaining therapeutic objectivesLluís Masana, Núria Plana
Clin Investig Arterioscler. 2019;31:271-7
5
4
Lessons learned by atherosclerotic plaques at necropsyMaria Borrell-Pages
Clin Investig Arterioscler. 2019;31:73-4
4